More Like This

Business Wire logo

Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK

Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions

New Government tech deals boost the business of cancer detection

From left to right: Dr. Iri Sato Baran, Genesis Healthcare (A.D.A.M Innovations), Vice Chair of the Board Ambassador Julia Longbottom, British Embassy Foreign, Commonwealth and Development Office Michel Mommejat, Genesis Healthcare (A.D.A.M Innovations), CEO and Executive Director Gretchen Weightman, Oxford Nanopore Technologies, Senior Vice President Commercial and General Manager APAC, Dr. Toshiharu Furukawa, LDP, Chair of Medical Information Policy and Genomic Medicine, House of Councillors, Hirokazu Shimoda, Japan Agency for Medical Research and Development, Senior Director

Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan

Prime Minister turbocharges medical research

Millions of vaccines to be made in Oxfordshire, and government unveils £50 million fund, in double boost for life sciences

ACCESSWIRE logo

Apple showcases Oxford Nanopore in M3 launch

UK’s "Quantum leap" to help beat disease, deliver high-paid jobs, and strengthen national security, as first country in the world to roll out Quantum computers at scale